Overview

Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Open-label study in two parallel groups of 20 healthy subjects each. Group A assessed the effect of CBZ on ESL pharmacokinetics, and Group B assessed the effect of ESL on CBZ pharmacokinetics.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Carbamazepine
Eslicarbazepine acetate